Induction of apoptosis by benzene metabolites in HL60 and CD34+ human bone marrow progenitor cells

Molecular Pharmacology

Volumn 50, Issue 3, 1996, Pages 610-615

  Moran, Julie L ^a   Siegel, David ^a   Sun, Xiao Ming ^a   Ross, David ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,4 BENZENETRIOL; BENZENE DERIVATIVE; CATECHOL; CD34 ANTIGEN; HOE 33342; HYDROQUINONE; PHENOL; PROPIDIUM IODIDE;

APOPTOSIS; ARTICLE; BONE MARROW TOXICITY; CELL STRAIN HL 60; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; FLUORESCENCE MICROSCOPY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TOXICOKINETICS;

ADULT; ANTIGENS, CD; ANTIGENS, CD34; APOPTOSIS; BENZENE; BENZENE DERIVATIVES; BIOLOGICAL MARKERS; BONE MARROW CELLS; CELL NUCLEUS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMATOPOIETIC STEM CELLS; HL-60 CELLS; HUMANS; HYDROQUINONES; MALE; PHENOLS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029838152     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Yardley-Jones, A., D. Anderson, and D. V. Parke. The toxicity of benzene and its metabolism and molecular pathology in human risk assessment. Br. J. Ind. Med. 48:437-444 (1991).
2. Aksoy, M. CRC Benzene Carcinogenicity. CRC Press, Boca Raton, (1988).
3. Snyder, R., G. Witz, and B. D. Goldstein. The toxicology of benzene. Environ. Health Perspect. 100:293-306 (1993).
4. Seaton, M. J., P. M. Schlosser, J. A. Bond, and M. A. Medinsky. Benzene metabolism by human liver microsomes in relation to cytochrome P450 2E1 activity. Carcinogenesis 15:1799-1806 (1994).
5. Rickert, D. E., T. S. Baker, J. S. Bus, C. S. Barrow, and R. D. Irons. Benzene disposition in the rat after exposure by inhalation. Toxicol. Appl. Pharmacol. 49:417-423 (1979).
6. Greenlee, W. F., J. D. Sun, and J. S. Bus. A proposed mechanism of benzene toxicity: formation of reactive intermediates from polyphenol metabolites. Toxicol. Appl. Pharmacol. 59:187-195 (1981).
7. Thomas, D. J., A. Sadler, V. Subrahmanyam, D. Siegel, M. J. Reasor, D. Wierda, and D. Ross. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells. Mol. Pharmacol. 37:255-262 (1990).
8. Irons, R. D. Quinones as toxic metabolites of benzene. J. Toxicol. Environ. Health 16:673-678 (1985).
9. Levay, G., D. Ross, and W. J. Bodell. Peroxidase activation of hydroquinone results in the formation of DNA adducts in HL-60 cells, mouse bone marrow macrophages and human bone marrow. Carcinogenesis 14:2329-2334 (1993).
10. Kolachana, P., V. V. Subrahmanyam, K. B. Meyer, L. Zhang, and M. T. Smith. Benzene and its phenolic metabolites produce oxidative DNA damage in HL60 cells in vitro and in the bone marrow in vivo. Cancer Res. 53:1023-1026 (1993).
11. Ross, D., H. Beall, R. D. Traver, D. Siegel, R. M. Phillips, and N. W. Gibson. Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies. Oncol. Res. 6:493-500 (1994).
12. Ganousis, L. G., D. Goon, T. Zyglewska, K. K. Wu, and D. Ross. Cell-specific metabolism in mouse bone marrow stroma: studies of activation and detoxification of benzene metabolites. Mol. Pharmacol. 42:1118-1125 (1992).
13. Thomas, D. J., M. J. Reasor, and D. Wierda. Macrophage regulation of myelopoiesis is altered by exposure to the benzene metabolite hydroquinone. Toxicol. Appl. Pharmacol. 97:440-453 (1989).
14. Green, J. D., C. A. Snyder, J. LoBue, B. D. Goldstein, and R. E. Albert. Acute and chronic dose/response effects of inhaled benzene on multipotential hematopoietic stem (CFU-S) and granulocyte/macrophage progenitor (GM-CFU-C) cells in CD-1 mice. Toxicol. Appl. Pharmacol. 58:492-503 (1981).
15. Cronkite, E. P., T. Inoue, A. L. Carsten, M. E. Miller, J. E. Bullis, and R. T. Drew. Effects of benzene inhalation on murine pluripotent stem cells. J. Toxicol. Environ. Health 9:411-421 (1982).
16. + human hematopoietic progenitor cells. Ann. Hematol. 70:281-296 (1995).
17. Wagner, J. E., D. Collins, S. Fuller, L. R. Schain, A. E. Berson, C. Almici, M. A. Hall, K. E. Chen, T. B. Okarma, and J. S. Lebkowski. Isolation of small, primitive human hematopoietic stem cells: distribution of cell surface cytokine receptors and growth in SCID-Hu mice. Blood 86:512-523 (1995).
18. + HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis. Blood Cells 17:287-295 (1991).
19. + normal human hematopoietic cells. Blood 82:2069-2078 (1993).
20. Schattenberg, D. G., W. S. Stillman, J. J. Gruntmeir, K. M. Helm, R. D. Irons, and D. Ross. Peroxidase activity in murine and human hematopoietic progenitor cells: potential relevance to benzene-induced toxicity. Mol. Pharmacol. 46:346-351 (1994).
21. Cotter, T. G., R. S. Fernandes, S. Verhaegen, and J. V. McCarthy. Cell death in the myeloid lineage. Immunol. Rev. 142:93-112 (1994).
22. Howie, S. E. M., D. J. Harrison, and A. H. Wyllie. Lymphocyte apoptosis-mechanisms and implications in disease. Immunol. Rev. 142:141-153 (1994).
23. Gorczyca, W., J. Gong, and Z. Darzynkiewicz. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53:1945-1951 (1993).
24. Brown, D. G., X.-M. Sun, and G. M. Cohen. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J. Biol. Chem. 268:3037-3039 (1993).
25. Ross, D., D. Siegel, N. W. Gibson, D. Pacheco, D. J. Thomas, M. Reasor, and D. Wierda. Activation and deactivation of quinones catalyzed by DT-diaphorase: evidence for bioreductive activation of diaziquone (AZQ) in human tumor cells and detoxification of benzene metabolites in bone marrow stroma. Free Radical Res. Commun. 8:373-381 (1990).
26. Twerdock, L. E., S. J. Rembish, and M. A. Trush. Induction of quinone reductase and glutathione in bone marrow cells by 1,2-dithiole-3-thione: effect on hydroquinone-induced cytotoxicity. Toxicol. Appl. Pharmacol. 112:273-281 (1992).
27. Subrahmanyam, V. V., P. Kolachana, and M. T. Smith. Metabolism of hydroquinone by human myeloperoxidase: mechanisms of stimulation by other phenolic compounds. Arch. Biochem. Biophys. 286:76-84 (1991).
28. Sarafian, T. A., and D. E. Bredesen. Is apoptosis mediated by reactive oxygen species? Free Radical Res. 21:1-8 (1994).
29. 3H]benzene. Biochem. Pharmacol. 26:293-300 (1977).
30. 14C-labelled benzene metabolites in the rat. Chem.-Biol. Interact. 33:285-299 (1981).
31. Young, N. S., and A. J. Barrett. The treatment of severe acquired aplastic anemia. Blood 85:3367-3377 (1995).
32. Young, N. S. Aplastic anemia. Lancet 1:228-232 (1995).
33. Scopes, J., M. Bagnara, E. C. Gordon-Smith, S. E. Ball, and F. M. Gibson. Haemopoietic progenitor cells are reduced in aplastic anemia. Br. J. Haematol. 86:427-430 (1994).
34. Marsh, J. C. W., J. Chang, N. G. Testa, J. M. Hows, and T. M. Dexter. In vitro assessment of marrow 'stem cell' and stromal cell function in aplastic anemia. Br. J. Haematol. 78:258-267 (1991).
35. Raza, A., S. Mundle, A. Iftikhar, S. Gregory, B. Marcus, Z. Khan, S. Alvi, V. Shetty, S. Dameron, V. Wright, S. Adler, J. M. Loew, S. Shott, S. N. Ali, and H. Preisler. Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am. J. Hematol. 48:143-154 (1995).
36. Socie, G., M. Henry-Amar, A. Bacigalupo, J. Hows, A. Tichelli, P. Ljungman, S. R. McCann, N. Frickhofen, E. V. T. Veer-Korthof, and E. Gluckman. Malignant tumors occurring after treatment of aplastic anemia. N. Engl. J. Med. 329:1152-1157 (1993).
37. Marsh, J. C. W., and C. G. Geary. Is aplastic anemia a pre-leukemic disorder? Br. J. Haematol. 77:447-452 (1991).